Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function

NCT02460783 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.

NCT NCT02460783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
Lead sponsor
National Institute on Aging (NIA)
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2015
Completion date
December 23, 2022
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, diabetes mellitus, obesity